Repligen (RGEN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.37 -0.16%
Revenue Growth %: +10.7%
Financial Fact:
Net (loss) income: 1.16M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +10.7%
Financial Fact:
Net (loss) income: 1.16M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $29.2 million versus the consensus estimate of $24.75 million.
GUIDANCE:
Repligen sees FY2016 EPS of $0.42-$0.48, versus the consensus of $0.47. Repligen sees FY2016 revenue of $101-105 million, versus the consensus of $99.5 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
